Forest Laboratories Holdings, Ltd. et al v. Mylan Pharmaceuticals Inc.
| Allergan USA, Inc., Allergan Sales, LLC, Ironwood Pharmaceuticals, Inc. and Forest Laboratories Holdings, LTD. |
| Mylan Pharmaceuticals Inc. |
| 1:2018cv00227 |
| December 19, 2018 |
| US District Court for the Northern District of West Virginia |
| Irene M Keeley |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 27, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 18 REPORT to USPTO on the filing or determination of an action regarding re #17 Order Dismissing Case. Copy to Trademark/Patent Office. (wrr) |
Filing 17
STIPULATION AND ORDER: This Stipulation And Order shall finally resolve the Action. All other claims, defenses, and counterclaims asserted by the parties against each other in Plaintiffs' and Mylan's pleadings in the Action, including the allegations and averments contained therein, are hereby dismissed, without prejudice. Signed by Senior Judge Irene M. Keeley on 12/27/2018. (wrr)
|
| Filing 16 STIPULATION of Dismissal and Order by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Filing 15 NOTICE of Appearance by James F. Companion on behalf of All Plaintiffs (Companion, James) |
|
Filing 14
ORDER SCHEDULING STATUS CONFERENCE: It is ORDERED that the Court SCHEDULES a Status Conference for 1/24/2019 01:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Signed by Senior Judge Irene M. Keeley on 12/20/18. (cnd)
|
| Filing 13 NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) |
| Filing 12 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Blumenfeld, Poff and Vrana re #11 Case Transferred In - District Transfer. (cnd) |
| Filing 11 Case transferred in from District of Delaware; Case Number 1:18-cv-00482. (cnd) |
|
Filing 10
SO ORDERED re (D.I. 270 in 16-cv-1114-RGA; D.I. 9 in 18-cv-482-RGA) Stipulation and Order. Signed by Judge Richard G. Andrews on 12/19/2018. Associated Cases: 1:16-cv-01114-RGA, 1:18-cv-00482-RGA(nms) [Transferred from Delaware on 12/19/2018.]
|
| Case transferred to the United States District Court for the Northern District of West Virginia, Clarksburg Division. (nms) [Transferred from Delaware on 12/19/2018.] |
| Filing 9 STIPULATION and Proposed Order, by Mylan Pharmaceuticals Inc.. (Vrana, Robert) Modified on 12/19/2018 (nms). [Transferred from Delaware on 12/19/2018.] |
| CORRECTING ENTRY: The stipulation filed at D.I. 9 has been removed per the directive at D.I. #8 . (nms) [Transferred from Delaware on 12/19/2018.] |
|
Filing 8
SO ORDERED Granting (7 in 18-cv-482-RGA, 151 in 16-cv-1114-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 4/13/2018. Associated Cases: 1:16-cv-01114-RGA, 1:18-cv-00482-RGA(nms) [Transferred from Delaware on 12/19/2018.]
|
|
Filing 7
STIPULATION and Order of Consolidation by Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Ironwood Pharmaceuticals, Inc., Allergan Sales LLC. (Noreika, Maryellen) [Transferred from Delaware on 12/19/2018.]
|
| Filing 6 SUMMONS Returned Executed by Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Allergan Sales, LLC, Ironwood Pharmaceuticals, Inc.. Mylan Pharmaceuticals Inc. served on 4/4/2018, answer due 4/25/2018. (Noreika, Maryellen) [Transferred from Delaware on 12/19/2018.] |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) [Transferred from Delaware on 12/19/2018.] |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd. filed by Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Ironwood Pharmaceuticals, Inc. (crb) [Transferred from Delaware on 12/19/2018.] |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,304,036 B2; 7,371,727 B2; 7,704,947 B2; 7,745,409 B2; 8,080,526 B2. (crb) [Transferred from Delaware on 12/19/2018.] |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/14/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 8/14/2020. (crb) [Transferred from Delaware on 12/19/2018.] |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) [Transferred from Delaware on 12/19/2018.] |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2351026.) - filed by Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Allergan Sales, LLC, Ironwood Pharmaceuticals, Inc. (Attachments: #1 Exhibit A - G, #2 Civil Cover Sheet)(crb) [Transferred from Delaware on 12/19/2018.] |
| Summons Issued with Magistrate Consent Notice attached as to Mylan Pharmaceuticals Inc. on 3/29/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) [Transferred from Delaware on 12/19/2018.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
